A carregar...
Effectiveness of Bortezomib in Cardiac AL Amyloidosis: A Report of Two Cases
Cardiac involvement is a major prognostic determinant in patients with primary AL amyloidosis. The clinical results of standard therapeutic approaches are suboptimal. It has been recently shown that bortezomib, an inhibitor of the proteasome, can induce rapid favourable responses in AL amyloidosis i...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3970246/ https://ncbi.nlm.nih.gov/pubmed/24715916 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/627474 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|